More particular markers, such as interleukin-6, interleukin-1, and TNF-α, play an important role in disease severity, especially in patients with acute respiratory distress syndrome (ARDS), but they are more expensive and not readily available for routine clinical use [9,10]. The gene discussed is IL6; the disease is acute respiratory distress syndrome.